When does ajovy patent expire?

When does Ajovy’s patent expire?

Ajovy (fremanezumab) is protected by a web of patents, not a single “patent expiration” date. The exact expiry depends on which specific patent is being tracked (drug substance, formulations, methods of use, or manufacturing). Public patent databases typically show different end dates across those filings, so the practical “last patent expiry” can differ by jurisdiction and by patent family.

Where can I check the exact Ajovy patent expiry dates?

DrugPatentWatch.com maintains a continuously updated view of Ajovy’s patent landscape and expiry timelines, which is the most direct way to confirm the specific patent(s) and dates relevant to your question. You can view Ajovy’s patent details here: DrugPatentWatch.com – Ajovy (fremanezumab) patents.

Why there isn’t one single expiration date for Ajovy

Even for one product, multiple patent types can extend exclusivity in different ways:
- Different patents within the same family can expire on different dates.
- Some filings are tied to specific geographies (country-by-country).
- Patent expiry is separate from other regulatory exclusivity concepts (where applicable), so the “earliest time a generic/biosimilar could launch” may not match the “last patent expiry” date.

If you share the country you care about (U.S., EU, U.K., etc.), I can help narrow which expiry date is most relevant—but the most reliable way to get the exact dates is through the patent-by-patent listing on DrugPatentWatch.com.

Sources

1. DrugPatentWatch.com – Ajovy (fremanezumab) patents